Urinary biomarkers of oxidative/nitrosative stress in healthy smokers

Inhalation Toxicology

Volumn 23, Issue 3, 2011, Pages 148-156

  Campos, Carlos ^a   Guzmán, Rodrigo ^a   López Fernández, Encarnación ^a   Casado, Ángela ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

biomarker; cigarette smoking; nitrosative stress; Oxidative stress; urine

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; HYDROGEN PEROXIDE; ISOPROSTANE; NITRATE; NITRIC OXIDE; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FLUOROMETRY; HUMAN; MALE; NITROSATIVE STRESS; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SPECTROPHOTOMETRY; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY; URINALYSIS;

ADULT; AGING; ANTIOXIDANTS; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DINOPROST; DNA DAMAGE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SMOKING; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 79952612331     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2011.554460     Document Type: Article

References (44)

1. Alessio L, Berlin A, Dell'Orto A, Tofoletto F, Ghezzi I. 1985. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health 55:99-106. (Pubitemid 15141233)
2. Banerjee D, Kumar AP, Kumar B, Madhusoodanan UK, Nayak S, Jacob J. 2002. Determination of absolute hydrogen peroxide concentration by spectrophotometric method. Curr Sci 83:1193-1194. (Pubitemid 135695275)
3. Basu S, Helmersson J, Jarosinska D, Sällsten G, Mazzolai B, Barregård L. 2009. Regulatory factors of basal F(2)-isoprostane formation: population, age, gender and smoking habits in humans. Free Radic Res 43:85-91.
4. Berr C, Coudray C, Bonithon-Kopp C, Roussel AM, Mainard F, Alperovitch A. 1998. Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study. Int J Vitam Nutr Res 68:26-35. (Pubitemid 28102129)
5. Cataldo JK, Prochaska JJ, Glantz SA. 2010. Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry afliation. J Alzheimers Dis 19:465-480.
6. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R, Cerami A. 1997. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94:13915-13920. (Pubitemid 28009684)
7. Dotan Y, Lichtenberg D, Pinchuk I. 2004. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43:200-227. (Pubitemid 38299193)
8. Eiserich JP, Vossen V O'Neill CA, Halliwell B, Cross CE, van der Vliet A. 1994. Molecular mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette smoke. FEBS Lett 353:53-56. (Pubitemid 24312542)
9. Feng S, Roethig HJ, Liang Q, Kinser R, Jin Y Scherer G, Urban M, Engl J, Riedel K. 2006. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'- deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 11:28-52. (Pubitemid 43250550)
10. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. 1990. Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87:4533-4537.
11. Giulivi C, Traaseth NJ, Davies KJ. 2003. Tyrosine oxidation products: analysis and biological relevance. Amino Acids 25:227-232. (Pubitemid 38041261)
12. Gniwotta C, Morrow JD, Roberts LJ 2nd, Kühn H. 1997. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Tromb Vasc Biol 17:3236-3241. (Pubitemid 28016083)
13. Halliwell B, Clement MV, Long LH. 2000. Hydrogen peroxide in the human body. FEBS Lett 486:10-13.
14. Halliwell B, Gutteridge JMC. 1999. Oxidative stress. In: Halliwell B, Gutteridge JMC, eds. Free radicals in biology and medicine. New York: Oxford University Press, 246-350.
15. Halliwell B, Long LH, Yee TP, Lim S, Kelly R. 2004. Establishing biomarkers of oxidative stress: the measurement of hydrogen peroxide in human urine. Curr Med Chem 11:1085-1092. (Pubitemid 38585054)
16. Jafé M. 1886. Über den niederschlag, welchen pikrinsäure in normalen harn erzeugt und über eine neue reaktion des kreatinins. Z Physiol Chem 10:391-400.
17. Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y Han S, Hatsukami DK. 2005. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev 14:2963-2968. (Pubitemid 43071219)
18. Kim DB, Oh YS, Yoo KD, Lee JM, Park CS, Ihm SH, Jang SW, Shim BJ, Kim HY, Seung KB, Rho TH, Kim JH. 2010. Passive smoking in never-smokers is associated with increased plasma homocysteine levels. Int Heart J 51:183-187.
19. Kovács T, Vas T, Wagner L, Schmelczer M, Kocsis B, Nagy J. 2000. Efect of smoking on urinary NOx and cGMP excretion in IgA nephropathy and in health. Contrib Nephrol 130:124-129.
20. Loft S, Astrup A, Buemann B, Poulsen HE. 1994. Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J 8:534-537. (Pubitemid 24161127)
21. Loft S, Poulsen HE. 1996. Cancer risk and oxidative DNA damage in man. J Mol Med 74:297-312. (Pubitemid 26195901)
22. Loft S, Poulsen HE. 1998. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim Pol 45:133-144. (Pubitemid 128646352)
23. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. 1992. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: infuence of smoking, gender and body mass index. Carcinogenesis 13:2241-2247. (Pubitemid 23022963)
24. Lykkesfeldt J. 2007. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380:50-58. (Pubitemid 46498044)
25. Marangon K, Herbeth B, Lecomte E, Paul-Dauphin A, Grolier P, Chancerelle Y Artur Y Siest G. 1998. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 67:231-239. (Pubitemid 28076714)
26. Miranda KM, Espey MG, Wink DA. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71. (Pubitemid 34146173)
27. Morrow J D, Frei B, Longmire AW, Gaziano J M, Lynch SM, Shyr Y Strauss WE, Oates JA, Roberts LJ 2nd. 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332:1198-1203.
28. Nakayama T, Kodama M, Nagata C 1984. Generation of hydrogen peroxide and superoxide anion radical from cigarette smoke. Gann 75:95-98. (Pubitemid 14155193)
29. Nia AB, Van Schooten FJ, Schilderman PA, De Kok TM, Haenen GR, Van Herwijnen MH, Van Agen E, Pachen D, Kleinjans JC 2001. A multi-biomarker approach to study the efects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms. Carcinogenesis, 22, 395-401. (Pubitemid 32203817)
30. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. 1998. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4:594-601. (Pubitemid 28523112)
31. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. 1997. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 79:1538-1541. (Pubitemid 27251080)
32. Nowak D, Antczak A, Krol M, Pietras T, Shariati B, Bialasiewicz P, Jeczkowski K, Kula P. 1996. Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J 9:652-657. (Pubitemid 26167866)
33. Orhan H, Coolen S, Meerman JH. 2005. Quantifcation of urinary o,o'-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometry. A comparison with ion-trap tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 827:104-108. (Pubitemid 41551603)
34. Pryor WA. 1997. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 105 Suppl 4:875-882. (Pubitemid 27372975)
35. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231-1237. (Pubitemid 29262709)
36. Rodgman A, Perfetti TA. 2009. Te chemical components of tobacco and tobacco smoke. Boca Raton, FL, USA: CRC Press, Taylor and Francis Group.
37. Sakano N, Takahashi N, Wang DH, Sauriasari R, Takemoto K, Kanbara S, Sato Y Takigawa T, Takaki J, Ogino K. 2009. Plasma 3-nitrotyrosine, urinary 8-isoprostane and 8-OHdG among healthy Japanese people. Free Radic Res 43:183-192.
38. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH. 2004. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 109:843-848. (Pubitemid 38252735)
39. Sobczak A, Wardas W, Zielinska-Danch W, Pawlicki K. 2004. Te infuence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clin Chem Lab Med 42:408-414. (Pubitemid 38585184)
40. Song MF, Li YS, Ootsuyama Y Kasai H, Kawai K, Ohta M, Eguchi Y Yamato H, Matsumoto Y Yoshida R, Ogawa Y 2009. Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. Free Radic Biol Med 47:41-46.
41. Uchiyama M, Mihara M. 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem, 86:271-278. (Pubitemid 9050395)
42. WHO. 2009. World Health Organization Report on the Global Tobacco Epidemic Geneva, Switzerland.
43. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraf J, Jungers P, Descamps-Latscha B. 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313. (Pubitemid 26166404)
44. Yanagisawa K, Makita Z, Shiroshita K, Ueda T, Fusegawa T, Kuwajima S, Takeuchi M, Koike T. 1998. Specifc fuorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 47:1348-1353. (Pubitemid 28523466)